ACAD
ACADIA Pharmaceuticals Inc
19.80$
+1.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.1% | 19.3% | 19.2% | 10.5% | 9.0% | 8.5% | 7.1% | 8.9% | 9.2% | 7.4% | 7.3% | 6.0% | 5.0% | 5.4% | 5.5% | 5.0% | 4.0% | 4.4% | 4.4% | 4.5% | 5.1% | 2.0% | 2.6% | 2.0% | 1.6% | 1.8% | 1.4% | 4.5% | 6.9% | 7.7% | 11.2% | 7.5% | 7.5% | 8.4% | 8.3% | 7.8% | 7.8% | 9.2% | 9.2% | 9.2% | 8.9% | |
| 74.9% | 80.7% | 80.8% | 89.5% | 91.0% | 91.5% | 92.9% | 91.1% | 90.8% | 92.6% | 92.7% | 94.0% | 95.0% | 94.6% | 94.5% | 95.0% | 96.0% | 95.6% | 95.6% | 95.5% | 94.9% | 98.0% | 97.4% | 98.0% | 98.4% | 98.2% | 98.6% | 95.5% | 93.1% | 92.3% | 88.8% | 92.5% | 92.5% | 91.6% | 91.7% | 92.2% | 92.2% | 90.8% | 90.8% | 90.8% | 91.1% | |
| 490.0% | 252.6% | 231.6% | 112.2% | 102.4% | 99.1% | 80.4% | 81.7% | 91.1% | 80.9% | 84.1% | 80.9% | 66.2% | 58.5% | 80.6% | 58.4% | 99.6% | 51.3% | 53.5% | 49.4% | 44.5% | 51.2% | 111.6% | 56.2% | 62.2% | 55.5% | 58.4% | 35.6% | 74.1% | 28.9% | 29.0% | 31.5% | 26.6% | 38.8% | 32.0% | 29.5% | 31.5% | 29.8% | 28.7% | 26.5% | 29.1% | |
| 959.3% | 482.1% | 430.1% | 201.9% | 175.0% | 117.3% | 124.7% | 121.7% | 104.8% | 57.9% | 147.9% | 81.7% | 76.9% | 93.4% | 113.2% | 76.6% | 67.7% | 57.6% | 104.8% | 84.0% | 62.1% | 74.0% | 83.7% | 66.8% | 59.8% | 72.5% | 85.5% | 58.1% | 46.2% | 44.2% | 52.5% | 48.4% | 53.2% | 50.1% | 51.7% | 50.5% | 47.9% | 54.8% | 63.8% | 52.0% | 54.5% | |
| 1,449.3% | 734.7% | 661.7% | 314.0% | 277.4% | 252.2% | 205.0% | 203.4% | 195.9% | 205.6% | 231.9% | 162.6% | 143.1% | 151.9% | 193.9% | 135.0% | 167.3% | 151.1% | 158.3% | 133.4% | 106.5% | 132.2% | 195.3% | 123.0% | 122.0% | 132.0% | 143.8% | 93.6% | 120.4% | 77.1% | 81.5% | 79.9% | 79.8% | 32.5% | 83.8% | 79.9% | 79.4% | 84.6% | 92.5% | 78.5% | 83.5% | |
| -1,374.3% | -654.0% | -581.0% | -224.6% | -186.4% | -160.7% | -112.2% | -112.3% | -105.1% | -112.9% | -139.2% | -68.6% | -48.0% | -57.4% | -99.4% | -40.0% | -71.2% | -55.5% | -62.7% | -37.9% | -11.6% | -34.2% | -97.9% | -25.0% | -23.6% | -33.7% | -45.2% | 1.8% | -27.3% | 15.1% | 7.4% | 12.6% | 12.6% | 59.1% | 7.9% | 12.2% | 12.8% | 6.1% | -1.7% | 12.3% | 7.6% | |
| 14.9% | 7.3% | 6.3% | 3.3% | 3.0% | 2.5% | 2.4% | 2.2% | 2.1% | 2.8% | 4.7% | 3.0% | 2.6% | 3.3% | 3.3% | 1.7% | 1.0% | 0.5% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.4% | 1.8% | 2.7% | 7.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1,359.4% | -646.7% | -574.7% | -221.3% | -183.4% | -158.2% | -109.8% | -110.5% | -105.9% | -109.9% | -134.9% | -65.6% | -44.7% | -53.5% | -97.7% | -37.9% | -70.4% | -54.8% | -62.3% | -37.7% | -11.2% | -32.8% | -97.5% | -24.9% | -20.2% | -30.0% | -37.9% | 3.8% | -24.6% | 17.2% | 10.2% | 15.4% | 15.5% | 62.1% | 11.4% | 15.2% | 16.0% | 9.3% | 1.5% | 15.1% | 10.7% | |
| 0.0% | 11.2% | 0.6% | 1.3% | 1.9% | -0.1% | 1.3% | 0.4% | 0.6% | 0.0% | 0.6% | 0.4% | -0.3% | 0.4% | -4.1% | 0.4% | -0.2% | 0.3% | 0.0% | 0.4% | -0.3% | 0.1% | 0.4% | 0.3% | 0.6% | 0.6% | -1.6% | 3.2% | 6.2% | -2.6% | 2.2% | 1.6% | 2.4% | 6.7% | 3.6% | 5.1% | -9.8% | -87.1% | 0.1% | 4.9% | -22.8% | |
| -1,359.4% | -657.9% | -574.7% | -221.3% | -183.4% | -158.1% | -111.1% | -110.9% | -106.6% | -109.9% | -135.5% | -66.0% | -44.4% | -53.9% | -97.7% | -38.3% | -70.2% | -55.2% | -62.4% | -38.1% | -11.0% | -33.0% | -97.9% | -25.3% | -20.8% | -30.6% | -36.3% | 0.7% | -30.8% | 19.8% | 8.0% | 13.8% | 13.1% | 55.4% | 7.8% | 10.1% | 25.8% | 96.3% | 1.4% | 10.2% | 33.4% | |
| -1,362.7% | -648.7% | -576.2% | -221.0% | -182.5% | -156.6% | -110.6% | -111.0% | -103.8% | -111.6% | -137.9% | -67.8% | -47.3% | -56.7% | -98.6% | -39.3% | -70.7% | -54.8% | -61.8% | -36.9% | -10.5% | -32.4% | -97.0% | -24.6% | -19.8% | -29.6% | -37.6% | 4.9% | -23.8% | 17.9% | 12.9% | 16.4% | 16.5% | 4.7% | 12.6% | 16.3% | 17.1% | 10.3% | 2.6% | 10.5% | 10.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.